The CD45 tyrosine phosphatase is required for T cell development and function by virtue of its role as a positive regulator of src family kinase activity. In addition, recent data have highlighted that CD45 also acts as a negative regulator of Lck function by dephosphorylation of critical tyrosine residues. Lck functionality and TCR responsiveness are elevated in transgenic mice expressing the CD45RO isoform at 'intermediate' (10-40% of wild type) levels, indicating that the expression level of CD45 is critical in determining the sensitivity of T cells to TCR stimulation. However, it is unclear whether such a phenotype is specific for the CD45RO isoform, typically expressed by activated T cells. In the present work, the roles of three isoforms of CD45, RO, RB and RABC, in thymocyte development, T cell responses and TCR signalling pathways were directly compared. The data demonstrate that expression of CD45RB or CD45RABC at intermediate levels also results in CD4
Introduction
Ligation of the T cell antigen receptor by peptide-MHC complexes triggers the phosphorylation of CD3 and f chain immunoreceptor tyrosine-based activation motifs by Srcfamily kinases (SFKs), initiating biochemical signalling pathways that result in the activation, differentiation and proliferation of effector T cells (1) . The CD45 phospho-tyrosine phosphatase (PTPase) is known to be an important regulator of TCR signalling through its ability to dephosphorylate critical tyrosine residues in the SFK p56 lck (Lck) and p59 fyn (Fyn) (2, 3) . In this regard, CD45 has long been known to be required for the maintenance of SFK functionality by dephosphorylation of an inhibitory C-terminal tyrosine residue (Tyr505 for Lck) (4, 5) . Thus, genetic ablation of CD45 expression in mice results in Lck Tyr505 hyper-phosphorylation, kinase dysfunction, failure of thymic selection processes and subsequently low numbers of mature peripheral T cells (6) (7) (8) .
In addition to acting as a positive regulator of TCR signalling, CD45 can also act to negatively regulate Lck function by virtue of its ability to dephosphorylate the active site Tyr394 residue (9, 10) . Recent data from our laboratory have suggested that the level of CD45 expression is critical in determining the sensitivity of cells to TCR stimulation (11) . Analysis of transgenic mice expressing the CD45RO isoform at a variety of levels/activity demonstrated that whereas low levels of CD45 are required to dephosphorylate sufficient phospho-Tyr505 to maintain Lck functionality, higher levels are required to maintain low levels of basal phospho-Tyr394 and prevent T cell hyper-responsiveness (11) .
A seemingly important, yet hitherto poorly understood, aspect of CD45 biology is its expression as multiple isoforms resulting from alternative splicing of exons 4-6 (A-C) of the Ptprc (CD45 encoding) gene. It is clear that expression of specific isoforms is tightly regulated in a cell-type-and activation status-dependent manner. As such, activated or 'memory' T cells express high levels of the shortest CD45RO isoform, whereas naive T cells tend to express longer CD45RA/B isoforms. However, the functional significance of isoform variation has yet to be elucidated. Some evidence has been provided to suggest that CD45 isoforms may differentially homodimerize, with potential implications for PTPase activity, or interact differentially with other cell surface molecules (12, 13) . Furthermore, the existence of isoformspecific ligands has been postulated (14) . The in vivo significance of these findings has yet to be determined.
In an attempt to elucidate isoform-specific functions of CD45, we, and others, have generated transgenic mice expressing single isoforms on a CD45-deficient background (15, 16) . Our initial analyses suggested that CD45RO and CD45RB were able to support T cell development to a similar extent (15) . However, our recent description of T cell hyperresponsiveness in CD45RO transgenic mice prompted us to question whether other isoforms supported a similar phenotype. In the present work, we have generated mice expressing the longest CD45RABC isoform and compared CD4 + T cell function in CD45RO, CD45RB and CD45RABC singleisoform-expressing mice. Our results show that expression of either CD45RB or CD45RABC at 35-45% of wild-type (WT) levels results in elevated CD4
+ T cell responses, as is the case for CD45RO, highlighting the importance of CD45 in both the negative and positive regulation of TCR signalling responses.
Materials and methods

Mice
All mice were bred and maintained in the small animal barrier unit at the Babraham Institute (Cambridge, UK), and all procedures were carried out under UK Home Office guidelines. CD45RABC cDNA was generated by the amplification of a 727-bp 5# fragment from B6 splenic mRNA and the replacement of the equivalent fragments of CD45RO cDNA as described previously for CD45RB (15) ; transgenic mice were created as previously described (15) . Genotyping of all transgenic mice was performed by PCR analysis of DNA extracted from tail biopsies with primers specific to the transgenic SV40 sequence (17) . Founder mice were mated with Ptprc (CD45) exon 9À/À mice (7) to generate transgenic animals lacking expression of endogenous CD45. Mice were backcrossed to a CD45À/À C57BL/6J background for a minimum of six generations. CD45RO3, CD45RO10 and CD45RB2 transgenic mice have previously been described (11, 15) . In all experiments, age-and sexmatched mice were analysed. Mice were analysed at 6-12 weeks of age.
Membrane PTPase activity
Membrane PTPase activity of thymocytes was assessed as previously reported (11) . Briefly, thymocytes were suspended in 20 mM HEPES, pH 7.4, 5 mM EDTA, 1 mM MgCl and 10 mM 2-mercaptoethanol and disrupted by sonication. Nuclei were pelleted by centrifugation, and the membrane fractions obtained by ultracentrifugation (95 000 3 g/90 min/4°C). Membrane pellets were re-suspended in 20 mM HEPES, 10 mM 2-mercaptoethanol and PTPase activity measured using the PTP Assay Kit 1 (Upstate Biotechnology, Southampton, UK). Activity was standardized to protein concentration as measured using the Biorad Protein Assay (Bio-Rad, Hemel Hempstead, UK).
T cell stimulation, flow cytometry and antibodies
Single-cell suspensions were stained for 30 min at 4°C with antibodies, diluted in PBS/1% FCS, to the following cell surface markers (obtained from BD PharMingen, Oxford, UK, unless stated otherwise): CD4 (YTA3.1, in house), CD8 (YTS169, in house), CD25 (PC61), CD45 (30-F11) and CD69 (H1-2F3). Cells were washed and processed on a FACSCalibur flow cytometer (BD PharMingen) and data analysed using FlowJo software (Tree Star, Ashland, OR, USA). For analysis of intracellular signalling, 10 7 lymph node cells ml
À1
were pre-warmed to 37°C for 30 min followed by stimulation with 10 lg ml À1 2C11 for 3 min. Stimulation was terminated by the addition of 2% formaldehyde prior to permeabilization in ice-cold 90% methanol. Cells were stained with anti-phospho-extracellular signal-regulated kinase (pERK) Thr202/ Tyr204 and anti-phospho-Akt (pAkt) Ser473 (both from Cell Signaling Technology, Hitchin, UK) and Cy5 Affinipure donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories, Newmarket, UK). Specificity was determined by use of MEK and phosphoinositide 3-kinase inhibitors for pERK and pAkt staining, respectively.
Western blotting
Western blotting was performed as previously described (18) . Briefly, 10 7 thymocytes were pre-incubated to 37°C and stimulated for 3 min with 10 lg ml À1 2C11. Cells were lysed in 1% Nonidet-P40, 60 lM octyl-glucoside, 200 mM Tris-HCl, 150 mM NaCl, 50 mM NaF, 20 mM EDTA 1 mM sodium orthovanadate and complete protease inhibitors. Proteins were resolved by SDS-PAGE and then transferred to nitrocellulose membranes. Non-specific binding was blocked by incubation of membranes in PBS/0.05% Tween 20/5% BSA, followed by incubation with the following primary antibodies: anti-phospho-tyrosine (4G10, in-house), anti-phospho SFK Y416, anti-phospho Lck Y505 and anti-Lck rabbit pAbs (all from Cell Signaling Technology). Anti-mouse and antirabbit HRP-conjugated secondary antibodies were used (DakoCytomation, Ely, UK) and bands were visualized using enhanced chemiluminescence (Amersham Biosciences, Little Chalfont, UK). Blots were stripped for 30 min at room temperature using low pH stripping buffer (pH 2.3) prior to reblocking and reprobing as described above.
CD4
+ T cell purification CD4 + T cells were purified from spleens and lymph nodes using the Spinsep Mouse T Cell Enrichment Kit (StemCell Technologies, London, UK), with the addition of anti-CD19 (1D3, BD PharMingen) and anti-CD8 (53.8.7, BD PharMingen). Purity of CD4 + T cells was >85% as determined by flow cytometry.
T cell culture, proliferation and cytokine assays
Purified WT, R0, RB or RABC CD4
+ T cells were cultured in 96-well plates coated with CD3e 6 CD28 mAbs. CD3 mAb concentration was as stated in figure legends, while CD28 mAb concentration was fixed at 5 lg ml À1 . Alternatively, 6-lm latex beads (Sigma Aldrich, Poole, UK) were coated with anti-CD3e and either anti-CD8 or anti-CD4 mAbs (all 0.1 lgml
À1
) and mixed with cells at a 1:1 cell:bead ratio. Proliferation was assessed by pulsing cells with 1 lCi of [ 3 H]thymidine (TdR) (Amersham Biosciences) during the last 16 h of a 60-h incubation. For cytokine analysis, culture supernatants were harvested after 24 or 48 h and ELISA performed using the following kits: IL-2, IL-4 and IFN-c (all from eBioscience, London, UK). Recombinant cytokines were used as controls.
Immunization protocol
Samples of pre-immune sera were taken 7 days prior to the initial immunization. Groups of female mice were immunized intra-peritoneally with 100 lg of trinitrophenol (TNP)-keyhole limpet haemocyanin (KLH) (Biosearch Technologies, Novato, CA, USA) emulsified in alum (Alu-Gel-S; Serva Electrophoresis, Abingdon, UK). Blood from tail veins was taken on day 11 post-immunization. For memory responses, mice received a further 100 lg of TNP-KLH on day 98. Tail bleeds were performed on day 105.
Statistical analysis
Two-tailed unpaired Student's t-test was performed. P values <0.01 were considered significant.
Results
Comparison of the roles for CD45RO, CD45RB and CD45RABC in thymic selection
Transgenic mice were generated expressing the CD45RABC isoform under control of the vav promoter. Founder mice were crossed with CD45-deficient animals to give expression of the individual CD45RABC isoform in the absence of endogenous CD45. Two lines of mice were generated: one line, designated RABC6, expressed CD45 at levels comparable to a previously described CD45RO-expressing transgenic line RO10 (11, 15) (17 6 1% versus 14 6 0.5% of WT levels, respectively; Fig. 1A) . A second line, RABC3, demonstrated mosaic expression of the CD45RABC transgene, such that ;50% of thymocytes expressed no or little CD45 (data not shown). However, as a result of the requirement for CD45 in positive selection (8) , all mature peripheral T cells in RABC3 mice expressed the CD45RABC transgene at a level comparable to previously described CD45RO-expressing RO3 and CD45RB-expressing RB2 lines ( Fig. 2A ) (15) (37 6 2.7%, 39 6 1.8% and 46 6 3% of WT levels for RABC3, RO3 and RB2, respectively).
To determine the CD45 activity in transgenic thymocytes, membranes were purified in the absence of detergent and PTPase activity assayed using a phosphopeptide substrate. In this assay, equal quantities of total membrane proteins were used for all mouse lines. In CD45À/À membranes, little or no PTPase activity was detected, while in CD45 transgenic membranes PTPase activity was directly proportional to CD45 expression level and was independent of which specific isoform was expressed (Fig. 1A) . For WT membranes, the high PTPase activity was a consequence of relatively higher CD45 expression as compared with CD45 transgenic lines.
We have previously reported that the selection of CD4SP thymocytes is enhanced in mice in which CD45RO is expressed at levels 10-60% of WT (11) . This phenotype was apparent for both RO3 and RO10 lines of mice and was associated with enhanced sensitivity of CD45RO transgenic thymocytes to anti-CD3 stimulation. In order to determine whether other CD45 isoforms generated a similar phenotype, flow cytometric analysis of RB2 and RABC6 thymi was performed. Figure 1 (B and C) shows that there was a marked increase in the positive selection of CD4SP thymocytes in RB2 and RABC6 thymocytes, comparable to expression-matched RO3 and RO10 controls, respectively.
To elucidate the molecular mechanisms underlying the increased selection of CD4SP thymocytes, TCR-induced signalling events in WT and CD45 transgenic thymocytes were assessed. Anti-CD3 stimulation resulted in higher total levels of tyrosine-phosphorylated proteins in RO3, RB2, RO10 and RABC6 thymocytes as compared with WT cells (Fig. 1D) . However, no differences between expression-matched CD45 isoform transgenic lines were apparent. The effect of specific isoform expression on Lck phosphorylation at activatory Tyr394 and inhibitory Tyr505 was also assessed. Importantly, phosphorylation levels of both Lck residues were comparable between expression-matched RO3/RB2 and RO10/RABC6 pairs (Fig. 1D) . Furthermore, phosphorylation at both residues was elevated in CD45 transgenic mice as compared with WT levels (Fig. 1D) . Finally, levels of phospho-Tyr505, and to a lesser extent phospho-Tyr394, were higher in the lower expressing RO10 and RABC6 lines as compared with the RO3 and RB2 lines, consistent with our previous studies (11) . Together, these data confirm that the expression level of CD45 is critical in determining selection processes and TCR signalling in thymocytes. Of particular note, CD45RO, CD45RB and CD45RABC appear to be equally capable of supporting thymic development and of mediating Lck dephosphorylation.
CD4
+ T cell responses are elevated in CD45 transgenic mice
+ T cells were purified from spleens and lymph nodes to compare the roles of CD45 isoforms in mature T cell function. Cells from RO3, RB2 and RABC3 (henceforth designated 'RO', 'RB' and 'RABC', respectively) mice expressed similar levels of CD45, allowing simultaneous and direct comparison of the function of these isoforms (Fig. 2A) . CD4 + T cells from all groups of mice had similar 'naive' cell surface marker phenotypes (CD44 low CD62L high) (data not shown). In response to either platebound anti-CD3 or anti-CD3+CD28 stimulation, RO CD4 + T cells proliferated to a greater extent than control C57BL/6 cells ( Fig. 2B and C) , as has been previously reported (11) . Interestingly, both RB and RABC CD4 + T cells also proliferated more than WT cells. No differences in the responses of RO versus RB or RABC transgenic cells were noted. Similarly, CD4
+ T cells from the lower expressing RO10 and RABC6 lines proliferated to an equivalent level (data not shown).
It is likely that CD45-mediated regulation of the activity of the CD4-associated pool of Lck is important for T cell responses (19) . Therefore, we assessed the responses of WT, RO, RB and RABC CD4 + T cells to CD3+CD4 stimulation. In these experiments, cells were cultured in the presence of antibody-coated beads and proliferation assessed by TdR incorporation. CD4 co-stimulation effectively increased the proliferation of WT cells when compared with CD3 stimulation alone (Fig. 2D) . As was the case for CD3 alone or CD3+CD28 stimulation, CD45 transgenic T cells responded to a greater extent in response to CD3+CD4 (Fig. 2D) . However, no consistent differences in the responses of the individual CD45 isoform lines to CD3+CD4 stimulation were noted.
The response of CD45 transgenic T cells to allogeneic MHC was also assessed by means of a mixed lymphocyte reaction. In these experiments, at low stimulator to responder cell ratios, CD45RO T cells proliferated more than WT cells (P < 0.05 for antigen-presenting cells (APCs):T cell ratios 0.5, 1 and 2; P > 0.05 for ratio 5) (Supplementary Figure 1a , available at International Immunology Online). By contrast, the response of WT, RO and RABC to superantigen stimulation was comparable (Supplementary Figure 1b, available at International Immunology Online), perhaps reflecting the Lck independence of such responses as has previously been reported (20) .
Next, we assessed the cytokine secretion profile of RO, RB and RABC transgenic CD4 + T cells. In response to CD3+CD28 stimulation, WT, RO, RB and RABC cells produced similar amounts of IL-2 (Fig. 3) . By contrast, CD45 transgenic CD4 + T cells produced ;2-fold more IFN-c than WT control cells (Fig. 3) . Strikingly, WT cells produced very low levels of IL-4 under these culture conditions, whereas transgenic CD4 + T cells produced 5-to 10-fold higher amounts (Fig. 3) . However, there were no consistent differences in the levels of either IFN-c or IL-4 production by RO as compared with RB and RABC-expressing transgenic lines.
Taken together, these data indicate that a reduction in the level of CD45 surface expression by trangenic CD4 + T cells results in increased responsiveness to TCR-co-receptor stimulation. Importantly, this hypersensitivity to stimulation appears to be equivalent for RO, RB and RABC singleisoform-expressing mice.
Thymus-dependent B cell responses in CD45 transgenic mice
The data from the in vitro analyses of T cell function indicated hyper-responsiveness of CD45 transgenic CD4 + cells. In order to determine whether this phenotype translated to the in vivo immune response, groups of WT, RO, RB and RABC mice were immunized with the T-dependent antigen TNP-KLH. Serum anti-TNP titres were assessed on day 11 after primary immunization and day 105 (7 days after secondary immunization). Pre-immune sera contained equivalent low levels of anti-TNP antibodies in all groups of mice (data not shown). All four groups of mice generated substantial primary and memory anti-TNP IgG1 responses, with no significant differences in antibody titres between any of the groups of mice (Fig. 4) . Furthermore, there were no significant differences between the groups of mice in the levels of total anti-TNP Ig, IgM or IgG2b at either time point (data not shown). Therefore, and in contrast to in vitro responses, the T-dependent response of CD45 transgenic mice is not elevated above WT levels.
CD45 transgenic T cells display elevated TCR signalling responses
The effects of CD45 isoform expression on TCR signalling events were investigated by stimulating mature lymph node T cells with anti-CD3e, followed by flow cytometric analysis. In the first series of experiments, cells were stimulated for 3 min and levels of pERK and pAkt assessed. The results showed that the proportions of pERK+ cells were higher for CD45 transgenic mice as compared with WT ( Fig 5A) . In addition, higher levels of pAkt were apparent in CD45 transgenic CD4
+ T cells as evidenced by the greater shift in fluorescence intensity (Fig. 5B) . No differences in the kinetics of ERK and Akt activation were apparent in any of the mouse lines assessed (data not shown). Finally, although similar proportions of cells in all groups of mice expressed CD25 and CD69 following 24 h of stimulation (data not shown), levels of activation marker expression on a per cell basis were higher for all three CD45 transgenic lines as compared with WT ( Fig. 5C and D) . While individual measurements showed some minor differences, analysis of multiple experiments showed no consistent evidence for altered signalling of RO versus RB and RABC cells.
Discussion
Our previous work has suggested that CD45 functions as a rheostat for TCR signalling sensitivity by virtue of its dual role as a positive and negative regulator of p56 lck function (11) . These data were generated by analysis of the effects of altering the expression levels of a single isoform, CD45RO, in transgenic mice. In the present work, we extend our initial findings to demonstrate that expression of either CD45RB or CD45RABC at 'intermediate' levels (35-45% WT) also results in a hyper-responsive CD4 + T cell phenotype. Therefore, in our experiments, it appears that the expression level of CD45 is critical in determining the sensitivity of cells to TCR stimulation, irrespective of which specific isoform is present. However, these data do not rule out the possibility of isoform-specific functions of CD45 (as discussed below).
Our data indicate that the selection of SP thymocytes is increased and that mature CD4 + T cells from CD45 transgenic mice proliferated more, produced greater quantities of effector cytokines, displayed enhanced levels of pERK and pAkt activation and up-regulated activation markers to a greater extent than WT cells upon TCR stimulation. Together, these data indicate that CD45 expression level is critical in determining TCR signalling sensitivity and, specifically, that high expression of CD45 is required to prevent T cell hyperresponsiveness. Historically, CD45 has been viewed predominantly as a positive regulator of TCR signalling, most clearly illustrated by the significant blocks in T cell development and function in CD45-deficient mice (6) (7) (8) . However, our data and those of others have indicated the complexity of CD45 function in T cells. In the present manuscript, we demonstrate that expression of intermediate levels of CD45RO, CD45RB or CD45RABC results in Lck hyperphosphorylation at both active Y394 and Y505 residues. It has been demonstrated that Y394 phosphorylation has amajor effect on Lck kinase activity, whereas Y505 has little effect on activity but may interfere with Lck protein interactions (21, 22) . At intermediate amounts of CD45 PTPase activity, the increase in pY394 appears to dominate Lck function, demonstrating that high levels of CD45 are required to restrain Lck activity under basal conditions (11) . In addition, Demetriou and colleagues have recently reported that the galectin lattice retains CD45 in T cell membrane microdomains, where the PTPase inactivates Lck and inhibits TCR signalling at the immune synapse (23) . This report complements the earlier findings that CD45 is absent from microclusters associated with prolonged TCR signalling but present in the central supramolecular activation cluster in which signalling is terminated (24) . Taken together, our data and these recent studies indicate that the expression level and membrane localization of CD45 are critical in the regulation of basal and receptor-triggered signalling in T cells. In contrast to the elevated in vitro responses of CD45 transgenic CD4 + T cells, the primary and memory T-dependent antibody responses of all groups of mice were equivalent. This apparently contradictory result might be explained by the fact that B cell function was not fully restored in our transgenic mice (15 and data not shown). Therefore, it would appear that B cells require a higher level of CD45 expression for full effector function, as compared with T cells.
Despite these results, no difference in the ability of the various isoforms of CD45 to mediate these effects was apparent. Earlier reports have suggested that the signalling capacity of primary human CD4 + CD45RA + T cells differs from that of CD4 + CD45RO + T cells (25) . Indeed, it has been clearly established that TCR signalling responses are altered in memory as compared with naive T cells (26, 27) . This, coupled to the fact that memory T cells tend to express the short CD45RO isoform whereas naive cells express longer CD45RA/B isoforms, has been taken as evidence for maturation stage-specific functions for CD45 isoforms in T cells. However, it has been recognized that CD45 isoform expression is not fixed and that memory CD45RO + T cells can revert to express higher molecular weight isoforms (28, 29) . Furthermore, it is known that a single WT T cell can simultaneously express several different CD45 isoforms (30) . These data imply that simple expression of a given CD45 isoform does not by itself determine the outcome of TCR stimulation, rather that the activation status and maturation state of the cell is critical for the nature of the signalling response. Given that our studies, and those of others, have failed to elucidate any isoform-specific functions of CD45 [the present work and refs (15, 16) ], can we conclude that CD45 isoforms are functionally equivalent? This would seem unlikely as the process of CD45 mRNA alternative splicing is highly evolutionarily conserved and represents an important expenditure of energy for a T cell during its maturation. Recent data from a number of laboratories suggest that CD45 isoforms may have differential propensities to form homoor heterodimers (3) . Dimerization of CD45 has been suggested to result in inhibition of PTPase activity through the occlusion of the catalytic site of one monomer by the 'wedge' domain of its adjacent partner. Mutation of the putative CD45 wedge domain results in autoimmunity and T and B cell hyper-responsiveness in mice (31, 32) . However, the structural basis for the wedge hypothesis remains controversial (33, 34) . It is also worthy of note that the autoimmune phenotype of the CD45 E613R mice requires the presence of B cells but not T cells (32) . This is somewhat unexpected given that B cells express high molecular weight CD45RABC (B220), a CD45 isoform with a relatively reduced propensity to homodimerize (13) , and therefore previously hypothesized to be less affected by the wedge mutation than lower molecular weight isoforms.
A possible alternative, but not mutually exclusive, hypothesis suggests that CD45 may have isoform-specific counter-receptors. Recent data proposed that the C-type lectin, macrophage galactose-like lectin (MGL), expressed by APC, interacts with CD45 in a glycosylation-dependent fashion and acted to inhibit Jurkat cell signalling (14) . In this regard, MGL binds higher molecular weight (more heavily glycosylated) isoforms of CD45 preferentially (14) . These data lead to the prediction that CD45RO-expressing T cells would be relatively less susceptible to negative regulation by MGL-expressing APC. Unfortunately, this hypothesis could not be addressed in the current work as the murine form of MGL has a different carbohydrate specificity to the human form and is not predicted to act as a CD45 receptor (14) . However, the possibility remains that as yet unidentified receptors may differentially affect CD45 isoform activity. Further work is required to test such theories and so, for the present time, isoform-specific roles of CD45 remain enigmatic.
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